Timothy Caulfield, JD, discusses the sessions he's most looking forward to at this year's Society for Pediatric Dermatology annual meeting, including his talk on overcoming misinformation in pediatric dermatology.
Timothy Caulfied, JD, professor in the Faculty of Law in the School of Public Health and research director of the Health Law Institute at the University of Alberta, discusses the sessions he's most looking forward to at this year's Society of Pediatric Dermatology (SPD) annual meeting, including his talk on overcoming misinformation in pediatric dermatology.
Transcript
What sessions are you most looking forward to checking out at SPD 2024?
You know, I'm really looking forward to talking to this community. First of all, I think this community is incredibly relevant. I think this is a hot topic for this community, for this audience. So I'm looking forward to engaging with them. And also [I'm] really interested in their thoughts about what kinds of issues in the misinformation sphere they're seeing. But the other reason I'm thrilled to have this opportunity is I think this community can make a real difference. We know that there's been an erosion in trust for institutions generally—for science and, yes, for physicians—but health care providers are still amongst the most trusted voices, especially when you're talking about that physician-patient relationship. So, yeah, [I'm] very excited to talk with this community and looking forward to the event.
What will audiences be able to take away from your presentation on misinformation in the field of pediatric dermatology?
Look, I hope it was obvious that this is a major problem. I think that the spread of health misinformation is one of the greatest challenges of our time, and I really tried to hammer that.
I don't think that's a hard sell for this community but the scope and the breadth of the problem is really tremendous. And so the presentation was a little bit a call to arms, right? You know, we need everyone to step up.
The Push for Fair Pricing and Reform in Pharmacy Benefit Management
April 3rd 2025Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to enhance transparency, reduce patient costs, and navigate the evolving healthcare landscape.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Using AI-Driven Strategies to Optimize Specialty Drug Costs, Manage Polypharmacy
April 2nd 2025As health care costs continue to rise, artificial intelligence (AI)-driven solutions are emerging as a powerful tool for managing specialty drug spending and polypharmacy risks, as showcased in recent research presented at the Academy of Managed Care Pharmacy 2025 conference.
Read More
How Recent Federal Policy Changes Are Shaping Managed Care Pharmacy
April 2nd 2025Federal legislative and regulatory changes are reshaping pharmacy practice, with key challenges in government funding, pharmacy benefit manager reform, and health care policy shifts—topics explored by experts at the Academy of Managed Care Pharmacy's annual meeting.
Read More
The IRA’s Unintended Consequences for Drug Pricing and Coverage
April 2nd 2025The Inflation Reduction Act (IRA) may be restricting Medicare Part D formularies, increasing patient costs, and stifling pharmaceutical innovation, experts warned at the Academy of Managed Care Pharmacy 2025 annual meeting.
Read More